WallStreetZenWallStreetZen

NASDAQ: TXMD
Therapeuticsmd Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TXMD past revenue growth

How has TXMD's revenue growth performed historically?
Company
-98.14%
Industry
10.18%
Market
17.2%
TXMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TXMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TXMD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TXMD earnings and revenue history

Current Revenue
$1.3M
Current Earnings
-$10.3M
Current Profit Margin
-789.4%

TXMD Return on Equity

Current Company
-34.1%
Current Industry
15.4%
Current Market
188%
TXMD's Return on Equity (-34.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TXMD announces earnings.

TXMD Return on Assets

Current Company
-19.9%
Current Industry
3.4%
TXMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TXMD Return on Capital Employed

Current Company
-28.31%
Current Industry
5.1%
TXMD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TXMD vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TXMD$1.30M-$9.40M-$10.28M-39.53%N/A
CPIX$39.55M$204.76k-$6.28M+6.15%N/A
TLPH$651.00k-$17.95M-$18.40M-21.26%N/A
HUGE$0.00-$11.32M-$13.16MN/AN/A
KALA$0.00-$35.91M-$42.20M-100.00%N/A
View Top Pharmaceutical Stocks

TXMD earnings dates

Next earnings date
May 13, 2024

Therapeuticsmd Earnings & Revenue FAQ

What were TXMD's earnings last quarter?

On Invalid Date, Therapeuticsmd (NASDAQ: TXMD) reported Q4 2023 earnings per share (EPS) of -$0.06, up 100.7% year over year. Total Therapeuticsmd earnings for the quarter were -$883.00 thousand. In the same quarter last year, Therapeuticsmd's earnings per share (EPS) was $8.55.

If you're new to stock investing, here's how to buy Therapeuticsmd stock.

What was TXMD's earnings growth in the past year?

As of Q2 2024, Therapeuticsmd's earnings has grown year over year. Therapeuticsmd's earnings in the past year totalled -$10.28 million.

What is TXMD's earnings date?

Therapeuticsmd's earnings date is Invalid Date. Add TXMD to your watchlist to be reminded of TXMD's next earnings announcement.

What was TXMD's revenue last quarter?

On Invalid Date, Therapeuticsmd (NASDAQ: TXMD) reported Q4 2023 revenue of $502.00 thousand up 99.27% year over year. In the same quarter last year, Therapeuticsmd's revenue was $68.57 million.

What was TXMD's revenue growth in the past year?

As of Q2 2024, Therapeuticsmd's revenue has grown -98.14% year over year. This is 108.32 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.18%. Therapeuticsmd's revenue in the past year totalled $1.30 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.